Physician profile
Robert L King
NPI 1457557829
$4,095.46
in general payments reported to CMS, 2019-2025
13 companies · $683 in 2025
The $683 reported for 2025 was more than what 82% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $125 · 2022: $52.16 · 2023: $471 · 2024: $2,404 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,514 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,514.41 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,928.62 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $389.90 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| W. L. Gore & Associates, INC. | $208.20 | 2019-2020 | |
| Tanabe Pharma America, INC. | $147.41 | 2019 | |
| Medtronic, INC. | $127.63 | 2022-2024 | Mvp, Venaseal, Closurefast |
| Ethicon US, LLC | $75.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Angiodynamics, INC. | $41.33 | 2019-2020 | |
| Philips North America LLC | $40.70 | 2024-2025 | Coronary Other, (8324) Azurion 7 M20 |
| Penumbra, INC. | $31.30 | 2024 | Penumbra System |
| Biotronik INC. | $27.64 | 2025 | Acticor 7 Vr-T Dx |
| Shockwave Medical, INC | $20.78 | 2025 | |
| Janssen Pharmaceuticals, INC | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.